Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) saw a large decline in short interest in the month of December. As of December 29th, there was short interest totalling 912,469 shares, a decline of 6.3% from the December 15th total of 974,176 shares. Approximately 7.0% of the company’s shares are sold short. Based on an average trading volume of 229,047 shares, the days-to-cover ratio is presently 4.0 days.
Separately, Maxim Group restated a “buy” rating and set a $1.50 price objective on shares of Xtant Medical in a report on Wednesday, November 22nd.
Xtant Medical (NYSEAMERICAN XTNT) opened at $0.56 on Friday. Xtant Medical has a 1-year low of $0.29 and a 1-year high of $1.21. The stock has a market capitalization of $10.09, a price-to-earnings ratio of -0.34 and a beta of 0.63.
TRADEMARK VIOLATION WARNING: “Xtant Medical Holdings Inc (XTNT) Short Interest Down 6.3% in December” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/01/14/xtant-medical-holdings-inc-xtnt-short-interest-down-6-3-in-december.html.
About Xtant Medical
Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.
Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.